SHR-8068 Injection Clinical Trials

3 actively recruiting trials

▼ -1 trial since August 2026

Pipeline

Phase 2: 1Phase 3: 1Phase 1/2: 1

Top Sponsors

Suzhou Suncadia Biopharmaceuticals Co., Ltd.2
Shanghai Hengrui Pharmaceutical Co., Ltd.1

Indications

Cancer3
Advanced Urothelial Carcinoma1
Advanced Biliary Tract Cancer1
Gastric Cancer1
Gastroesophageal-junction Cancer1

Other3 trials

A Phase III Study of SHR-8068 in Combination With Adebrelimab and Platinum-Containing Chemotherapy Versus Durvalumab in Combination With Platinum-Containing Chemotherapy as First-line Treatment for Advanced Biliary Tract Cancer (BTC)

Phase 3

A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ Cancer

Phase 2

A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.